Entry Detail



General Information

Database ID:exR0354280
RNA Name:hsa-miR-27a-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:-
Coordinate:
Start Site(bp):13836447End Site(bp):13836467
External Links:hsa-miR-27a-3p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
IGF2BP3
chr7
23310209
23470491
-
SOX11
chr2
5692384
5701385
+
AEN
chr15
88621337
88632281
+
SUCO
chr1
172532349
172611833
+
ALDH3A2
chr17
19648136
19685760
+
CD2AP
chr6
47477789
47627263
+
TTYH3
chr7
2631986
2664802
+
C1orf116
chr1
207018522
207032756
-
GLTP
chr12
109850945
109880541
-
PAX9
chr14
36657568
36679362
+
TMEM30A
chr6
75252924
75284948
-
NUAK1
chr12
106063340
106140033
-
LGALS8
chr1
236518000
236552981
+
ACER3
chr11
76860867
77026797
+
NEK2
chr1
211658657
211675630
-
CDR2
chr16
22345936
22437165
-
B4GALT3
chr1
161171310
161177968
-
JRK
chr8
142657460
142681968
-
KCNK1
chr1
233614106
233672514
+
ACLY
chr17
41866917
41930542
-
TMX4
chr20
7977346
8019805
-
PPP1CC
chr12
110719680
110742939
-
KPNA6
chr1
32108056
32176563
+
HTT
chr4
3041422
3243960
+
NF1
chr17
31094927
31382116
+
ETNK1
chr12
22625075
22690665
+
ZBTB34
chr9
126860665
126885878
+
CANX
chr5
179678628
179731641
+
PAK1
chr11
77321707
77474635
-
GIPC1
chr19
14477760
14496149
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0001247
chr22
46125304
46136418
+
hsa_circ_0000942
chr19
46020920
46021352
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010980.2
chr2
222317242
222318653
-
AC021092.1
chr19
44103007
44113183
-
AC022150.4
chr19
52650437
52653284
-
AC093010.3
chr3
114314501
114329714
-
AL050341.2
chr1
40256427
40257967
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC01089
chr12
121795267
121803906
-
LINC02381
chr12
54126082
54147485
+
NEAT1
chr11
65422774
65445540
+
SDCBP2-AS1
chr20
1325405
1378735
+
SNHG22
chr18
49814023
49851059
+
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.